The ASCO Post Podcast

View Top 200 Chart

Back to Rankings Page

Science
**The ASCO Post Podcast**

News and views from the world of clinical oncology and hematology.

Latest Episodes:

Recent Trial Findings in Genitourinary Oncology Nov 04, 2022

Show notes

On this episode, we’re hearing from authors of recent impactful research in the field of genitourinary oncology.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

FDA Approvals in Hepatocellular Carcinoma and Multiple Myeloma Oct 28, 2022

Show notes

On this episode, we’re covering two recent approvals from the U.S. Food and Drug Administration (FDA): one in unresectable hepatocellular carcinoma, and one in relapsed or refractory multiple myeloma.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

Effects of Mortgage Discrimination on Cancer Care Outcomes Oct 14, 2022

Show notes

On this episode, we’re covering two studies that focused on the effects of mortgage discrimination on cancer care outcomes. The research—in colon and lung cancers—was presented during the 2022 ASCO Quality Care Symposium.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

ESMO 2022: Updates in Skin Cancer Oct 07, 2022

Show notes

On this episode, we’re highlighting speakers who presented data in skin cancers during the ESMO Congress 2022, including findings on tumor-infiltrating lymphocyte therapy in advanced melanoma, cemiplimab in cutaneous squamous cell carcinoma, and the association of circulating tumor DNA and disease recurrence in patients with later-stage melanoma.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

Highlights From the 2022 ASCO Quality Care Symposium Oct 03, 2022

Show notes

The 2022 ASCO Quality Care Symposium took place in Chicago over the weekend. On this episode, we’re featuring two speakers who presented data at the meeting: the first focuses on the effects of Medicaid expansion on cancer mortality rates, and the second describes efforts to improve prescribing practices for prophylactic colony stimulating factors in the treatment of neutropenia.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

ESMO 2022: Updates in Breast Cancer Sep 23, 2022

Show notes

On this episode, we’re highlighting speakers who presented data in breast cancer during the ESMO Congress 2022. The first speaker discusses patterns of genomic instability in metastatic breast cancer, and the second touches on oncofertility care for young patients with breast cancer.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

Highlights From the ESMO Congress 2022 Sep 16, 2022

Show notes

The ESMO Congress 2022 took place in Paris from September 9 to 13. In this episode, we highlight key research presented at the meeting. We’ll first hear from the presenting author of Abstract LBA1 on the effect of air pollutants on the risk of non–small cell lung cancer. Then, we’ll hear from a researcher on the SWOG S1801 team on the benefits of different therapeutic strategies using pembrolizumab in patients with advanced melanoma. Finally, we’ll hear about the results of the IMmotion 010 study of adjuvant atezolizumab for renal cell carcinoma post-nephrectomy.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

FDA Approval of Pemigatinib and Update From the STAMPEDE Trial Sep 02, 2022

Show notes

This week, we’re covering the FDA approval of pemigatinib for patients with myeloid or lymphoid neoplasms and an FGFR1 rearrangement. We’ll also discuss a long-term update from the STAMPEDE trial of radiotherapy in prostate cancer.

Coverage of stories discussed this week on ascopost.com:

FDA Approves Pemigatinib for Patients With Myeloid/Lymphoid Neoplasms and FGFR1 Rearrangement

Long-Term Benefit of Radiotherapy Confirmed in Advanced Prostate Cancer: STAMPEDE Trial Follow-up

To listen to more podcasts from ASCO, visit asco.org/podcasts.

Highlights From the European Hematology Association 2022 Congress Aug 26, 2022

Show notes

In this episode, we’re featuring two speakers presenting data from the European Hematology Association 2022 Congress, focusing on findings in acute myeloid leukemia and diffuse large B-cell lymphoma.

To listen to more podcasts from ASCO, visit asco.org/podcasts.

ASCO 2022: Conversations in Colorectal Cancer Aug 19, 2022

Show notes

On this episode, we’re featuring discussions about data in colorectal cancer that were presented at the 2022 ASCO Annual Meeting. Dr. Michael Overman, of The University of Texas MD Anderson Cancer Center, speaks with two presenters about guiding therapy with circulating tumor DNA and refining treatment strategies for RAS wild-type metastatic disease.

To listen to more podcasts from ASCO, visit asco.org/podcasts.